Aceragen (STU:V9Z) FCF Margin % : -398.87% (As of Mar. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Aceragen FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Aceragen's Free Cash Flow for the three months ended in Mar. 2023 was €-9.20 Mil. Aceragen's Revenue for the three months ended in Mar. 2023 was €2.31 Mil. Therefore, Aceragen's FCF Margin % for the quarter that ended in Mar. 2023 was -398.87%.

As of today, Aceragen's current FCF Yield % is 0.00%.

The historical rank and industry rank for Aceragen's FCF Margin % or its related term are showing as below:

STU:V9Z' s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0
Current: -409.22

STU:V9Z's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -145.04 vs STU:V9Z: -409.22

Aceragen FCF Margin % Historical Data

The historical data trend for Aceragen's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aceragen FCF Margin % Chart

Aceragen Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-7,852.23

-3,074.29

-503.77

Aceragen Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
FCF Margin %	Get a 7-Day Free Trial															-	-	-6,591.84	-274.38	-398.87

Competitive Comparison of Aceragen's FCF Margin %

For the Biotechnology subindustry, Aceragen's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aceragen's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aceragen's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Aceragen's FCF Margin % falls into.

Aceragen FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Aceragen's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-23.123	/	4.59
	=	-503.77 %

Aceragen's FCF Margin for the quarter that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	-9.202	/	2.307
	=	-398.87 %

Aceragen FCF Margin % Related Terms

Thank you for viewing the detailed overview of Aceragen's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aceragen (STU:V9Z) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aceragen Inc (STU:V9Z) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

505 Eagleview Boulevard, Suite 212, Exton, PA, USA, 19341

Website

https://www.aceragen.com

Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.

Aceragen (STU:V9Z) Headlines

No Headlines